Clinical Trials
27 trialsNCT07035067 2026-04-07
Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in Canada
PeriPharm
Terminated
NCT03189108 2026-01-02
Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors
National Institutes of Health Clinical Center (CC)
Terminated
NCT05124743 2025-07-30
HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid Tumors
Alaunos Therapeutics
Terminated
NCT05891197 2025-07-01
START
Lyell Immunopharma, Inc.
Terminated
NCT05352217 2024-04-22
ECOvar
Stiftung Swiss Tumor Institute
Terminated
NCT03128294 2024-04-19
Long Term Survivors in Ovarian Cancer
University Medical Center Groningen
Terminated
NCT02341118 2023-07-27
Capturing BRCA1/2 Mutational Status in Women With High Grade Serous Ovarian Cancer and Impact on Clinical Outcome.
University Health Network, Toronto
Terminated
NCT01881451 2022-02-17
Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or Metastatic Clear Cell Ovarian Cancer
British Columbia Cancer Agency
Terminated
NCT04367467 2022-01-26
Effect of PARP Inhibitors on Glomerular Filtration Rate
University of Pennsylvania
Terminated
NCT03203993 2020-10-14
CRONUS
AstraZeneca
Terminated
NCT02769546 2020-04-02
Physician-Patient Communication and Expectations Regarding Ovarian Cancer Prognosis
Abramson Cancer Center at Penn Medicine
Terminated
NCT03485651 2020-02-06
Natera Ovarian Cancer Detection Assay
Natera, Inc.
Terminated
NCT01374685 2019-12-03
Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans
National Institutes of Health Clinical Center (CC)
Terminated
NCT00651716 2019-11-15
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Terminated
NCT02900248 2019-04-02
N1
CureOne
Terminated
NCT00899093 2018-05-22
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy
GOG Foundation
Terminated
NCT00900068 2017-05-09
Blood Samples From Patients on a Clinical Trial to CINV During HSCT
OHSU Knight Cancer Institute
Terminated
NCT00596544 2015-11-26
Sexual Functioning After Primary Treatment of Ovarian Cancer
Memorial Sloan Kettering Cancer Center
Terminated
NCT01175967 2015-10-12
Use of Palliative Performance and Symptom Distress Scales in Older Patients With Advanced Ovarian Cancer
UNC Lineberger Comprehensive Cancer Center
Terminated
NCT00536523 2014-08-22
Effect of Serotonin Level on Constipation Caused by Chemotherapy in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
University of Minnesota
Terminated
NCT00003794 2013-06-10
Quality-of-Life Study of Patients With Previously Treated Ovarian Cancer
GOG Foundation
Terminated
NCT00288275 2012-10-05
Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube Cancer
Precision Therapeutics
Terminated
NCT00669422 2012-10-05
ChemoFx® PRO - A Post-Market Data Collection Study
Precision Therapeutics
Terminated
NCT00897806 2012-07-30
Identifying Genetic Markers That Predict Response to Paclitaxel in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
M.D. Anderson Cancer Center
Terminated
NCT01096381 2012-02-27
Potential Biomarkers for Bevacizumab-Induced High Blood Pressure in Patients With Solid Tumor
Vanderbilt-Ingram Cancer Center
Terminated
NCT00898781 2011-07-19
Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer
Mayo Clinic
Terminated
NCT00531778 2011-01-11
NYU Ovarian Cancer Early Detection Program Blood and Genetics
NYU Langone Health
Terminated